久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Signant Health brings its eConsent solution to China biospectrumasia
    September 16, 2019
    The investigator-initiated schizophrenia focus trial, which will be the first Chinese study using Signant's TrialConsent solution, will involve hundreds of patients from multiple sites.
PharmaSources Customer Service